Cargando…
Thrombolytic treatment (alteplase; rt-Pa) in acute massive pulmonary embolism and cardiopulmonary arrest
Patients with pulmonary thromboembolism (PE) often decompensate suddenly, and once hemodynamic compromise has developed, mortality is extremely high. Currently, thrombolytic therapy for PE is still controversial. We retrospectively evaluated 34 patients with PE between January 2010 and December 2013...
Autores principales: | Dirican, Adem, Ozkaya, Sevket, Atas, Ali Ekber, Ulu, Esra Kayahan, Kitapci, Ilknur, Ece, Ferah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061167/ https://www.ncbi.nlm.nih.gov/pubmed/24959070 http://dx.doi.org/10.2147/DDDT.S61679 |
Ejemplares similares
-
The rapid effects of budesonide plus formoterol in patients with obstructive airway diseases
por: Bayiz, Hulya, et al.
Publicado: (2015) -
Safety and Efficacy of Thrombolytic Therapy Using rt-PA (Alteplase) in Acute Ischemic Stroke
por: Sivanandy, Palanisamy, et al.
Publicado: (2011) -
The relationship between early reversibility test and maximal inspiratory pressure in patients with airway obstruction
por: Ozkaya, Sevket, et al.
Publicado: (2014) -
Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?
por: Mahmood, Ammad, et al.
Publicado: (2022) -
The objective evaluation of obstructive pulmonary diseases with spirometry
por: Ozkaya, Sevket, et al.
Publicado: (2016)